Literature DB >> 33743055

Minimum clinically important change for outcome scores among patients aged 75 or over undergoing lumbar spine surgery.

Kosei Nagata1,2, Hideki Nakamoto1,2, So Kato1,2, Yujiro Takeshita2,3, Naohiro Kawamura2,4, Takashi Ono2,5, Akiro Higashikawa2,6, Masayoshi Fukushima2,7, Seiichi Azuma2,8, Nobuhiro Hara2,9, Hiroyuki Oka2,10, Ko Matsudaira2,10, Sakae Tanaka1, Yasushi Oshima11,12.   

Abstract

PURPOSE: To elucidate the minimum clinically important change (MCIC) of the physical component summary (PCS) of the Short Form-12, Oswestry Disability Index (ODI), EuroQOL-5 dimensions (EQ-5D), and the Core Outcome Measures Index (COMI) in patients aged ≥ 75 years undergoing lumbar spine surgery.
METHODS: We retrospectively reviewed patients aged ≥ 75 years with degenerative lumbar spine disease who underwent lumbar spine decompression or fusion surgery within three levels between April 2017 and June 2018. We also evaluated patients aged < 75 years in the same period as reference. We evaluated the baseline and postoperative PCS, ODI, EQ-5D, and COMI scores. Patients were asked to answer an anchor question regarding health transition for MCICs using the anchor-based method.
RESULTS: A total of 247 patients aged ≥ 75 years and 398 patients aged < 75 years were included for analysis. Of patients aged ≥ 75 years, 83.4% showed at least "somewhat improved" outcomes, while 91.0% of patients aged < 75 years reported this outcome. PCS change score was not adequately correlated to health transition in patients aged ≥ 75 years. Receiver operating characteristic curve analyses revealed MCICs of 17.8 for ODI, 0.18 for EQ-5D, and 1.6 for COMI in patients aged ≥ 75 years, and 12.7 for ODI, 0.19 for EQ-5D, and 2.3 for COMI in patients aged < 75 years.
CONCLUSION: In patients aged ≥ 75 years, PCS may not be feasible for evaluation of health transition. The MCIC value for ODI score was higher and that for EQ-5D/COMI score was lower in patients aged ≥ 75 years, compared with those in patients aged < 75 years.

Entities:  

Keywords:  Euro-quality of life-5 dimensions; The Oswestry disability index; The core outcome measures index; The minimum clinically important change; The physical component summary

Year:  2021        PMID: 33743055     DOI: 10.1007/s00586-021-06815-2

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  22 in total

1.  Estimating an EQ-5D population value set: the case of Japan.

Authors:  Aki Tsuchiya; Shunya Ikeda; Naoki Ikegami; Shuzo Nishimura; Ikuro Sakai; Takashi Fukuda; Chisato Hamashima; Akinori Hisashige; Makoto Tamura
Journal:  Health Econ       Date:  2002-06       Impact factor: 3.046

Review 2.  Understanding the minimum clinically important difference: a review of concepts and methods.

Authors:  Anne G Copay; Brian R Subach; Steven D Glassman; David W Polly; Thomas C Schuler
Journal:  Spine J       Date:  2007-04-02       Impact factor: 4.166

3.  How does patient-rated outcome change over time following the surgical treatment of degenerative disorders of the thoracolumbar spine?

Authors:  Tamas F Fekete; M Loibl; D Jeszenszky; D Haschtmann; P Banczerowski; F S Kleinstück; H J Becker; F Porchet; A F Mannion
Journal:  Eur Spine J       Date:  2017-10-27       Impact factor: 3.134

4.  Validity of the Japanese Core Outcome Measures Index (COMI)-Back for thoracic and lumbar spine surgery: a prospective cohort study.

Authors:  Kosei Nagata; Yasushi Oshima; Hideki Nakamoto; Ryuji Sakamoto; Nozomu Ohtomo; Masaaki Izuka; Koji Nakajima; Takahiko Yoshimoto; Tomoko Fujii; Ko Matsudaira; Sakae Tanaka; Hiroyuki Oka
Journal:  Eur Spine J       Date:  2019-12-16       Impact factor: 3.134

5.  The Oswestry low back pain disability questionnaire.

Authors:  J C Fairbank; J Couper; J B Davies; J P O'Brien
Journal:  Physiotherapy       Date:  1980-08       Impact factor: 3.358

6.  Minimum clinically important difference in outcome scores among patients undergoing cervical laminoplasty.

Authors:  So Kato; Yasushi Oshima; Yoshitaka Matsubayashi; Yuki Taniguchi; Sakae Tanaka; Katsushi Takeshita
Journal:  Eur Spine J       Date:  2019-03-14       Impact factor: 3.134

7.  Utility of minimum clinically important difference in assessing pain, disability, and health state after transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis.

Authors:  Scott L Parker; Owoicho Adogwa; Alexandra R Paul; William N Anderson; Oran Aaronson; Joseph S Cheng; Matthew J McGirt
Journal:  J Neurosurg Spine       Date:  2011-02-18

8.  Minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain scales.

Authors:  Anne G Copay; Steven D Glassman; Brian R Subach; Sigurd Berven; Thomas C Schuler; Leah Y Carreon
Journal:  Spine J       Date:  2008-01-16       Impact factor: 4.166

9.  Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis.

Authors:  Scott L Parker; Owoicho Adogwa; Stephen K Mendenhall; David N Shau; William N Anderson; Joseph S Cheng; Clinton J Devin; Matthew J McGirt
Journal:  Spine J       Date:  2012-11-14       Impact factor: 4.166

10.  Estimation of minimal clinically important change of the Japanese version of EQ-5D in patients with chronic noncancer pain: a retrospective research using real-world data.

Authors:  Kazutake Yoshizawa; Hisanori Kobayashi; Motoko Fujie; Yoshimasa Ogawa; Tsutomu Yajima; Koji Kawai
Journal:  Health Qual Life Outcomes       Date:  2016-03-01       Impact factor: 3.186

View more
  1 in total

1.  Effect of diabetes on patient-reported outcome measures at one year after laminoplasty for cervical spondylotic myelopathy.

Authors:  Kosei Nagata; Junya Miyahara; Hideki Nakamoto; Naohiro Kawamura; Yujiro Takeshita; Akiro Higashikawa; Takashi Ono; Masayoshi Fukushima; Rentaro Okazaki; Nobuhiro Hara; So Kato; Toru Doi; Yuki Taniguchi; Yoshitaka Matsubayashi; Sakae Tanaka; Yasushi Oshima
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.